Rankings
▼
Calendar
PLRX Q4 2021 Earnings — Pliant Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena
PLRX
Pliant Therapeutics, Inc.
$82M
Q4 2021 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$2M
-55.2% YoY
Gross Profit
$2M
100.0% margin
Operating Income
-$25M
-1230.6% margin
Net Income
-$25M
-1227.2% margin
EPS (Diluted)
$-0.68
QoQ Revenue Growth
+24.2%
Cash Flow
Operating Cash Flow
-$20M
Free Cash Flow
-$20M
Stock-Based Comp.
$3M
Balance Sheet
Total Assets
$221M
Total Liabilities
$22M
Stockholders' Equity
$199M
Cash & Equivalents
$52M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$2M
$4M
-55.2%
Gross Profit
$2M
$4M
-55.2%
Operating Income
-$25M
-$19M
-29.4%
Net Income
-$25M
-$19M
-28.9%
← FY 2021
All Quarters
Q1 2022 →